Efficacy of immune-checkpoint inhibitors in advanced non-small cell lung cancer patients with different metastases

BACKGROUND: To investigate the significance of metastatic sites and their numbers to the efficacy of immune checkpoint inhibitors (ICIs) in patients with advanced non-small cell lung cancer (NSCLC). METHODS: A total of 232 patients who received ICI monotherapy or ICI-based combination therapy were r...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Ann Transl Med
Glavni autori: Qiao, Meng, Zhou, Fei, Hou, Likun, Li, Xuefei, Zhao, Chao, Jiang, Tao, Gao, Guanghui, Su, Chunxia, Wu, Chunyan, Ren, Shengxiang, Zhou, Caicun
Format: Artigo
Jezik:Inglês
Izdano: AME Publishing Company 2021
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7859789/
https://ncbi.nlm.nih.gov/pubmed/33553327
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm-20-1471
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items